{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:04:24Z","timestamp":1790103864319,"version":"4.0.1"},"reference-count":33,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W014491\/1"],"award-info":[{"award-number":["MR\/W014491\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To understand how prevalence estimates of single and multiple organ fibrosis have changed from 2012 to 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective population-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Data from primary (Clinical Practice Research Datalink Aurum) and secondary care (Hospital Episode Statistics Admitted Patient Care) electronic health records were used to conduct this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults aged 18 years and older whose primary and secondary care records were available for research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>Fibrotic conditions previously determined from a Delphi survey of clinicians; diagnoses were found in either primary or secondary care records. The primary analysis estimated the prevalence of both single and multiple organ fibrosis. A secondary analysis used Cox proportional hazards models to investigate the association between the time-updated number of fibrotic conditions and risk of death, adjusting for age and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort consisted of 5\u2009839\u2009459 people with at least one fibrotic condition and a denominator of 18\u2009784\u2009962 people. Over the study period, prevalence of fibrotic conditions increased by 6.72%, and as of 2022, 19.95% (95% CI 19.92% to 19.98%) of adults had at least one fibrotic condition. The prevalence of multiple organ fibrosis increased from 4.78% (95% CI 4.76% to 4.79%) in 2012 to 8.51% (95% CI 8.50% to 8.53%) in 2022. In the year preceding diagnosis of single organ fibrosis, the median number of primary care consultations was 14 compared with 21 consultations for people with multiple organ fibrosis. Compared with people with single organ fibrosis, people with two fibrotic conditions had a mortality HR of 2.90 (95% CI 2.87 to 2.93), while people with three fibrotic conditions had a mortality HR of 5.22 (95% CI 5.14 to 5.30).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prevalence of single and multiple organ fibrosis has substantially increased over a decade. People with multiple organ fibrosis access healthcare more than people with single organ fibrosis and are at a greater risk of mortality. Multiple organ fibrosis is estimated to affect more than 3 million people in the UK and is increasing. Better understanding of patterns of fibrotic multimorbidity may help to aid earlier diagnosis and opportunities for reducing mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-113800","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:35:47Z","timestamp":1790102147000},"page":"e113800","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal trends in single and multiple organ fibrosis prevalence and primary care consultations: a population-based cohort study of 5.8 million individuals in England"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4355-6546","authenticated-orcid":false,"given":"Georgie May","family":"Massen","sequence":"first","affiliation":[{"name":"School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisli","family":"Jenkins","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Allen","sequence":"additional","affiliation":[{"name":"Division of Public Health and Epidemiology, University of Leicester, Leicester, England, UK"},{"name":"NIHR Leicester Biomedical Research Centre, Leicester, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-2688","authenticated-orcid":false,"given":"Iain","family":"Stewart","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9671-9057","authenticated-orcid":false,"given":"Chris J","family":"Scotton","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Exeter, Exeter, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine (UCL Respiratory), University College London, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Longhurst","sequence":"additional","affiliation":[{"name":"Dyskeratosis Congenita (DC) Action, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise V","family":"Wain","sequence":"additional","affiliation":[{"name":"Division of Public Health and Epidemiology, University of Leicester, Leicester, Leicestershire, UK"},{"name":"The Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, Leicestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Navaratnam","sequence":"additional","affiliation":[{"name":"Institute for Respiratory Health, The University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-4869","authenticated-orcid":false,"given":"Jennifer K","family":"Quint","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026092211353364000_16.9.e113800.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2016.03.004"},{"key":"2026092211353364000_16.9.e113800.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2016.07.008"},{"key":"2026092211353364000_16.9.e113800.3","doi-asserted-by":"crossref","unstructured":"Willadsen T , Siersma V , Nicolaisd\u00f3ttir D , et al . Multimorbidity and mortality. J Comorb 2018;8. doi:10.1177\/2235042X18804063","DOI":"10.1177\/2235042X18804063"},{"key":"2026092211353364000_16.9.e113800.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-020-1425-3","article-title":"Associations between complex multimorbidity, activities of daily living and mortality among older Norwegians. A prospective cohort study: the HUNT Study, Norway","volume":"20","author":"Storeng","year":"2020","journal-title":"BMC Geriatr"},{"key":"2026092211353364000_16.9.e113800.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1305-x","article-title":"Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort","volume":"17","author":"Jani","year":"2019","journal-title":"BMC Med"},{"key":"2026092211353364000_16.9.e113800.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100149","article-title":"Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank","volume":"8","author":"Ronaldson","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026092211353364000_16.9.e113800.7","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-2-51","article-title":"Multimorbidity and quality of life in primary care: a systematic review","volume":"2","author":"Fortin","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"2026092211353364000_16.9.e113800.8","unstructured":"Our Ageing Population | The State of Ageing 2025. Centre for Ageing Better. Available: https:\/\/ageing-better.org.uk\/our-ageing-population-state-ageing-2025 [Accessed 4 Sep 2025]."},{"key":"2026092211353364000_16.9.e113800.9","unstructured":"Multiple Long-Term Conditions (Multimorbidity): a priority for global health research. Available: https:\/\/acmedsci.ac.uk\/policy\/policy-projects\/multimorbidity [Accessed 13 Jul 2023]."},{"key":"2026092211353364000_16.9.e113800.10","doi-asserted-by":"crossref","unstructured":"Ritti\u00e9 L , ed. Fibrosis: Methods and protocols. New York, NY: Springer New York, 2017.","DOI":"10.1007\/978-1-4939-7113-8"},{"key":"2026092211353364000_16.9.e113800.11","doi-asserted-by":"publisher","DOI":"10.1038\/nri1412"},{"key":"2026092211353364000_16.9.e113800.12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/CLEP.S463499","article-title":"Using Routinely Collected Electronic Healthcare Record Data to Investigate Fibrotic Multimorbidity in England","volume":"16","author":"Massen","year":"2024","journal-title":"Clin Epidemiol"},{"key":"2026092211353364000_16.9.e113800.13","unstructured":"CPRD Aurum December 2024 dataset. Available: https:\/\/www.cprd.com\/doi\/cprd-aurum-december-2024-dataset [Accessed 11 Mar 2025]."},{"key":"2026092211353364000_16.9.e113800.14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz034"},{"key":"2026092211353364000_16.9.e113800.15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/qjmed\/hcad050","article-title":"Classifying the unclassifiable\u2014a Delphi study to reach consensus on the fibrotic nature of diseases","volume":"116","author":"Massen","year":"2023","journal-title":"QJM"},{"key":"2026092211353364000_16.9.e113800.16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/eurjpc\/zwaf068","article-title":"The association between fibrotic diseases and treatment-resistant hypertension in England","volume":"33","author":"Massen","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"2026092211353364000_16.9.e113800.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-103426","article-title":"Association between hyperglycaemia, diabetes complications and development of fibrotic conditions among people living with type 1 and type 2 diabetes in England: a retrospective cohort study using UK Clinical Resource Datalink Aurum and Hospital Episode Statistics","volume":"15","author":"Massen","year":"2025","journal-title":"BMJ Open"},{"key":"2026092211353364000_16.9.e113800.18","unstructured":"Sex by age. Office for National Statistics. Available: https:\/\/www.ons.gov.uk\/datasets\/RM121\/editions\/2021\/versions\/1 [Accessed 10 Aug 2026]."},{"key":"2026092211353364000_16.9.e113800.19","unstructured":"Ethnic group by age and sex, england and wales. Office for National Statistics. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/culturalidentity\/ethnicity\/articles\/ethnicgroupbyageandsexenglandandwales\/census2021 [Accessed 30 May 2025]."},{"key":"2026092211353364000_16.9.e113800.20","unstructured":"StataCorp . Stata statistical software: release 17. College Station, TX: StataCorp LLC; 2021."},{"key":"2026092211353364000_16.9.e113800.21","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423610000484"},{"key":"2026092211353364000_16.9.e113800.22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2020.03.008","article-title":"Sex related differences in the pathogenesis of organ fibrosis","volume":"222","author":"Garate-Carrillo","year":"2020","journal-title":"Translational Research"},{"key":"2026092211353364000_16.9.e113800.23","doi-asserted-by":"crossref","first-page":"53714","DOI":"10.18632\/oncotarget.16342","article-title":"Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"2026092211353364000_16.9.e113800.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.078"},{"key":"2026092211353364000_16.9.e113800.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62470-4"},{"key":"2026092211353364000_16.9.e113800.26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26761"},{"key":"2026092211353364000_16.9.e113800.27","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000085","article-title":"Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection","volume":"10","author":"Xiong","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"2026092211353364000_16.9.e113800.28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1112062"},{"key":"2026092211353364000_16.9.e113800.29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/aja.aja_80_20","article-title":"Testosterone, cardiomyopathies, and heart failure: a narrative review","volume":"23","author":"Diaconu","year":"2021","journal-title":"Asian J Androl"},{"key":"2026092211353364000_16.9.e113800.30","unstructured":"Cellular immune mechanisms in coxsackievirus group B, type 3 induced myocarditis in balb\/c mice. SpringerLink. Available: https:\/\/link.springer.com\/chapter\/10.1007\/978-1-4684-4472-8_29 [Accessed 6 Jul 2025]."},{"key":"2026092211353364000_16.9.e113800.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2006.07.009"},{"key":"2026092211353364000_16.9.e113800.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn3100"},{"key":"2026092211353364000_16.9.e113800.33","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-00966-9","article-title":"Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis","volume":"5","author":"Bjurling","year":"2025","journal-title":"Commun Med (Lond)"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-113800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:35:51Z","timestamp":1790102151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-113800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,22]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjopen-2025-113800"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-113800","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}